These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7295886)

  • 1. Plasma propranolol concentrations in rats with adjuvant-induced arthritis.
    Bishop H; Schneider RE; Welling PG
    Biopharm Drug Dispos; 1981; 2(3):291-7. PubMed ID: 7295886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of l-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats.
    Terao N; Shen DD
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):479-93. PubMed ID: 6520744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
    Walker KA; Barber HE; Hawksworth GM
    Drug Metab Dispos; 1986; 14(4):482-6. PubMed ID: 2873997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diflunisal pharmacodynamics in experimental arthritis in rats.
    Walker JS; Kasmerski L
    J Rheumatol; 1988 Nov; 15(11):1643-7. PubMed ID: 3266249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High capacity for pulmonary first-pass elimination of propranolol in rats.
    Iwamoto K; Watanabe J; Aoyama Y
    J Pharm Pharmacol; 1987 Dec; 39(12):1049-51. PubMed ID: 2894439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone secretion in the rat in response to an adjuvant arthritis challenge.
    Latman NS; Kishore V; Bruot B
    Arthritis Rheum; 1986 Mar; 29(3):411-4. PubMed ID: 3964316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
    Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
    Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.
    Piquette-Miller M; Jamali F
    Drug Metab Dispos; 1995 Feb; 23(2):240-5. PubMed ID: 7736918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats.
    Connolly KM; Stecher VJ; Pruden DJ
    Ann Rheum Dis; 1988 Jun; 47(6):515-21. PubMed ID: 3260094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic prednisolone administration on plasma copper in rats with adjuvant arthritis.
    Fontaine J; Peretz A; Neve J; Pelen F; Famaey JP
    Int J Tissue React; 1991; 13(6):295-8. PubMed ID: 1818042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of aging on the stereoselective pharmacokinetics of propranolol in the rat.
    Vermeulen AM; Belpaire FM; Moerman E; de Smet F; Bogaert MG
    Chirality; 1992; 4(2):73-9. PubMed ID: 1616826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on the hepatic clearance of propranolol in rats.
    Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
    J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
    Pollock SH; Matthews HW; D'Souza MJ
    Drug Metab Dispos; 1989; 17(6):595-9. PubMed ID: 2575493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered S(--)-propranolol disposition in bilateral ureter-ligated rats.
    Laganière S; Shen DD
    Nephron; 1987; 46(3):305-11. PubMed ID: 3627324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay.
    Piquette-Miller M; Jamali F
    Pharm Res; 1993 Feb; 10(2):294-9. PubMed ID: 8456080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effects of cimetidine on elimination and distribution of propranolol in rats.
    Shibasaki S; Asahina M; Kawamata Y; Kojo M; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Sep; 12(9):549-57. PubMed ID: 2614643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No stereoselective first-pass hepatic extraction of propranolol.
    Jackman GP; McLean AJ; Jennings GL; Bobik A
    Clin Pharmacol Ther; 1981 Sep; 30(3):291-6. PubMed ID: 7273593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in plasma protein binding properties of propranolol and flurbiprofen during development of adjuvant-induced arthritis in rats.
    Kawase A; Ikuta H; Uno S; Yamamoto K; Akitsu N; Nagao T; Iwaki M
    Xenobiotica; 2013 Mar; 43(3):246-52. PubMed ID: 22867272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclosporin on the pharmacokinetics of propranolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Ku YS
    J Pharm Pharmacol; 1999 Oct; 51(10):1149-54. PubMed ID: 10579686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absorption of propranolol from the jejunum in rats with adjuvant-induced arthritis.
    Key BJ; Mucklow CA; Bishop H
    Biopharm Drug Dispos; 1986; 7(3):233-7. PubMed ID: 3730523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.